OncLive SOSS

Genomic Testing for Improved Treatments in Breast Cancer - Episode 3

MammaPrint: A 70-Gene Signature Test for Patient with Breast Cancer

February 8, 2024

Joyce O’Shaughnessy, MD, Erin Cobain, MD

Dr. O’Shaughnessy introduces MammaPrint and BluePrint, discussing their role in genomic testing for patients with breast cancer.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Evolving Treatment Paradigms for Early-Stage Breast Cancers

EP. 2: Overview of Genomic Assays for Early-Stage Breast Cancer

EP. 3: MammaPrint: A 70-Gene Signature Test for Patient with Breast Cancer

EP. 4: Clinical Considerations of Genomic Testing in Early-Stage Breast Cancer

EP. 5: FLEX Trial: Genomic Testing of HER2 Status in ER+/HER2-Breast Cancer

EP. 6: Exploring Multigene Genomic Assays in High-Risk BC Patients

EP. 7: Real-World Evidence in Genomic Testing from SABCS 2023

EP. 8: Racial Disparities and Genomic Testing for Breast Cancer Patients

EP. 9: Reflecting on Genomic Testing in Practice for Breast Cancer

EP. 10: Ongoing Studies in Genomic Testing for Breast Cancer

x